- Home
- VOR vs SYRS Comparison
VOR vs SYRS Comparison
Compare VOR & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- SYRS
- Stock Information
- Founded
- VOR 2015
- SYRS 2011
- Country
- VOR United States
- SYRS United States
- Employees
- VOR N/A
- SYRS N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- VOR Health Care
- SYRS Health Care
- Exchange
- VOR Nasdaq
- SYRS Nasdaq
- Market Cap
- VOR 59.3M
- SYRS 52.5M
- IPO Year
- VOR 2021
- SYRS 2016
- Fundamental
- Price
- VOR $0.79
- SYRS $0.26
- Analyst Decision
- VOR Strong Buy
- SYRS Hold
- Analyst Count
- VOR 7
- SYRS 5
- Target Price
- VOR $11.36
- SYRS $3.00
- AVG Volume (30 Days)
- VOR 612.6K
- SYRS 23.8M
- Earning Date
- VOR 11-07-2024
- SYRS 10-31-2024
- Dividend Yield
- VOR N/A
- SYRS N/A
- EPS Growth
- VOR N/A
- SYRS N/A
- EPS
- VOR N/A
- SYRS N/A
- Revenue
- VOR N/A
- SYRS $386,000.00
- Revenue This Year
- VOR N/A
- SYRS N/A
- Revenue Next Year
- VOR N/A
- SYRS $1,011.11
- P/E Ratio
- VOR N/A
- SYRS N/A
- Revenue Growth
- VOR N/A
- SYRS N/A
- 52 Week Low
- VOR $0.63
- SYRS $0.18
- 52 Week High
- VOR $3.14
- SYRS $8.17
- Technical
- Relative Strength Index (RSI)
- VOR 46.07
- SYRS 28.67
- Support Level
- VOR $0.72
- SYRS $0.18
- Resistance Level
- VOR $0.82
- SYRS $0.37
- Average True Range (ATR)
- VOR 0.08
- SYRS 0.22
- MACD
- VOR -0.01
- SYRS -0.23
- Stochastic Oscillator
- VOR 17.71
- SYRS 2.39
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.